A multi-center study for clinical response of choline acetyltransferase and apolipoprotein epsilon gene polymorphisms to donepezil in Alzheimer's disease
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2015
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Eisai Korea
- 13 Jul 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 07 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.